CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy is a research paper published in Radiotherapy and Oncology (2020). On theSindex it has a DataRank of 0.416. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: K08 CA226350
NCI NIH HHS
Grant: R01 CA184153
NCI NIH HHS
Grant: U01 CA183848
National Institutes of Health
Grant: 5R01CA184153-02
Functional imaging-directed adaptive therapy of head and neck cancer
National Institutes of Health
Grant: 5U01CA183848-05
Quantitative MRI models of HN Cancers for Physiological Adaption of RT
National Institutes of Health
FWCI
1.77
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy
Additional file 1 of Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy